Fundies.
English

CATABASIS PHARMACEUTICALS INC

EDGAR
ATXS Current report (8-K) · filed 2026-01-23

113 filing records in this dataset, filed from 2015-05-13 to 2026-01-23. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

700 thousand Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g

2025 Q3 · Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g

Exact inputs and evidence
  • Revenue: 700000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g Source

Operating margin

-4,872%

2025 Q3 · %

Exact inputs and evidence
  • Operating Income: -34104000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g Source
  • Revenue: 700000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g Source
Cash and cash equivalents
96.3 million Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g Source
Exact value

96280000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g

Long-term debt including current maturities
833 thousand Unit1 Source
Exact value

833000 Unit1

Shares outstanding
56.4 million Unit_Standard_shares_CpCXh-LLOEiLNBZxHqhUOg Source
Exact value

56434894 Unit_Standard_shares_CpCXh-LLOEiLNBZxHqhUOg

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-01-23.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2017-12-31
  • Operating income: 2 of 11 periods available· newest 2024-12-31
  • Net income: 2 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2024-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2024-12-31
  • Total assets: Multiple units; comparison withheld· newest 2024-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2024-12-31
  • Current assets: Multiple units; comparison withheld· newest 2024-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2024-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2024-12-31
  • Long-term debt including current maturities: 3 of 11 periods available· newest 2017-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 21.37 million

    Prior period

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 72.89 million

    –

    Current period

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 94.26 million

    –

    Exact inputs and evidence

    -94260000 − -72891000 = -21369000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

    -72891000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -94260000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 12.77 million

    Prior period

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 68.45 million

    –

    Current period

    −Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 81.21 million

    –

    Exact inputs and evidence

    -81212000 − -68445000 = -12767000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

    -68445000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -81212000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +1,200%

    Prior period

    Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 25,000

    –

    Current period

    Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 325,000

    –

    Exact inputs and evidence

    325000 − 25000 = 300000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

    25000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    325000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

  • Revenue Unit1 500,000 100% of revenue
  • Operating costs Derived Unavailable An input is unavailable.
  • Operating income Unavailable An input is unavailable.
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow Unavailable An input is unavailable.
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2017 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2017 2017-01-01 – 2017-12-31500000 UnavailableUnavailableUnavailableUnavailableUnavailable
Source

Amounts are exact, in Unit1.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit1 500K 2017
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.540.0K405.0K270.0K135.0K0.02017
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit1)Source evidence
2017Revenue500000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2017Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2017-12-31Operating marginNot reported
2017-12-31Net marginNot reported
2017Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit1)Source evidence
2017Operating cash flowNot reportedNo source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValueSource evidence
2017Free cash flowUnavailableNo source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2017-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2017-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 72.89 million
Exact value

Exact value: -72891000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2023-01-01 – 2023-12-31: -72891000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 68.45 million
Exact value

Exact value: -68445000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2023-01-01 – 2023-12-31: -68445000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 25,000
Exact value

Exact value: 25000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2023-01-01 – 2023-12-31: 25000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 68.47 million
Calculation and evidence

-68445000 − 25000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

Exact free cash flow: -68470000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 94.26 million
Exact value

Exact value: -94260000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2024-01-01 – 2024-12-31: -94260000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 81.21 million
Exact value

Exact value: -81212000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2024-01-01 – 2024-12-31: -81212000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 325,000
Exact value

Exact value: 325000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

2024-01-01 – 2024-12-31: 325000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ 81.54 million
Calculation and evidence

-81212000 − 325000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

Exact free cash flow: -81537000 Unit_Standard_USD_EDhfdNIjCUWfeJjkPUFNgQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

113 filings · 3,371 latest values · 3,371 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001454789, 1454789, ATXS, CATB, edgar:1454789

Also known as Astria Therapeutics, Inc., Astria Therapeutics, Inc., CATABASIS PHARMACEUTICALS INC, Catabasis Pharmaceuticals, Inc.